- Report
- February 2026
- 250 Pages
Global
From €4005EUR$4,490USD£3,435GBP
- Report
- February 2026
- 250 Pages
Global
From €4005EUR$4,490USD£3,435GBP
- Report
- November 2025
- 181 Pages
Global
From €3162EUR$3,545USD£2,712GBP
€3513EUR$3,939USD£3,013GBP
- Report
- May 2026
- 185 Pages
Global
From €4014EUR$4,500USD£3,443GBP
- Report
- May 2026
- 177 Pages
Global
From €4014EUR$4,500USD£3,443GBP
- Report
- January 2026
- 180 Pages
Global
From €4014EUR$4,500USD£3,443GBP
- Report
- September 2025
- 185 Pages
Global
From €4014EUR$4,500USD£3,443GBP
- Report
- January 2026
- 186 Pages
Global
From €4014EUR$4,500USD£3,443GBP
- Report
- February 2026
- 250 Pages
Global
From €4005EUR$4,490USD£3,435GBP
- Report
- February 2026
- 250 Pages
Global
From €4005EUR$4,490USD£3,435GBP
- Report
- February 2026
- 250 Pages
Global
From €4005EUR$4,490USD£3,435GBP
- Report
- February 2026
- 250 Pages
Global
From €4005EUR$4,490USD£3,435GBP
- Report
- February 2026
- 250 Pages
Global
From €4005EUR$4,490USD£3,435GBP
- Report
- September 2026
- 365 Pages
Global
From €5218EUR$5,850USD£4,475GBP
- Report
- September 2026
- 566 Pages
Global
From €5218EUR$5,850USD£4,475GBP
- Report
- September 2026
- 267 Pages
Global
From €5218EUR$5,850USD£4,475GBP
- Report
- July 2026
- 295 Pages
Global
From €7127EUR$7,990USD£6,113GBP
- Report
- July 2026
- 200 Pages
Global
From €7127EUR$7,990USD£6,113GBP
- Report
- July 2026
- 400 Pages
Global
From €7127EUR$7,990USD£6,113GBP
- Report
- April 2026
- 30 Pages
Global
From €2453EUR$2,750USD£2,104GBP

Interleukins are a group of cytokines, or proteins, that are involved in the regulation of the immune system. They are produced by a variety of cells, including T cells, B cells, and macrophages, and are involved in a wide range of biological processes, including inflammation, cell growth, and differentiation. Genomics has enabled researchers to better understand the role of interleukins in the immune system, and to develop new therapies for a variety of diseases.
In recent years, the interleukin market has grown significantly, with a number of companies developing new therapies and diagnostic tests. Companies such as AbbVie, Amgen, and Novartis are developing new interleukin-based therapies for a variety of diseases, while companies such as Genentech and Merck are developing diagnostic tests to detect interleukin levels in patients. Additionally, a number of biotechnology companies are developing new interleukin-based therapies for a variety of diseases. Show Less Read more